In Vitro Evaluation and Monitoring of the Expression Level and Localization of Aldose Reductase Using Functionalized Quantum Dots and EGFP

다국어 초록 (Multilingual Abstract)

The optimization of aldose reductase (AR) expression levels and tracking of the AR expression sites within the cell is an essential step in developing a platform for the effective production of aldose reductase inhibitors (ARIs). In this study, we have demonstrated the use of both immunocytochemistry and quantum dots-based immunofluorescence techniques for observing and detecting the expression level and localization of AR in the cytoplasm and cell membrane of a eukaryotic cell model with high levels of AR protein expression. Our results show that high expression levels of human AR can be achieved using the eukaryotic cell model that we have developed. The overexpressed AR can be used for translational studies of hAR and the screening of ARIs. More importantly, the use of the established quantum dots-based immunofluorescence technique in the intracellular labeling of AR allows the determination of the expression and distribution of the AR gene. Overall, the use of the interdisciplinary approach of both genetic engineering and quantum dot-based immunofluorescence allows not only the effective production of a desired protein, but also the determination of the cellular localization of such an expressed protein.

참고문헌 (Reference)

1 Monton, H, "The use of quantum dots for immunochemistry applications" 906 : 185-192, 2012

2 Alivisatos, P, "The use of nanocrystals in biological detection" 22 : 47-52, 2004

3 Bruchez, M. Jr, "Semiconductor nanocrystals as fluorescent biological labels" 281 : 2013-2016, 1998

4 Pitsillides, C. M, "Selective cell targeting with light-absorbing microparticles and nanoparticles" 84 : 4023-4032, 2003

5 Gu, J, "Research progress in aldose reductase" 35 : 395-400, 2010

6 Chan, W. C, "Quantum dot bioconjugates for ultrasensitive nonisotopic detection" 281 : 2016-2018, 1998

7 Medintz, I. L, "Quantum dot bioconjugates for imaging, labelling and sensing" 4 : 435-446, 2005

8 Scholz, O, "Quantitative analysis of gene expression with an improved green fluorescent protein. p6" 267 : 1565-1570, 2000

9 Hasuike, Y, "Plasma 3-deoxyglucosone elevation in chronic renal failure is associated with increased aldose reductase in erythrocytes" 40 : 464-471, 2002

10 Kang, E. S, "Phorbol ester up-regulates aldose reductase expression in A549cells: A potential role for aldose reductase in cell cycle modulation" 62 : 1146-1155, 2005

11 Jaiswal, J. K, "Long-term multiple color imaging of live cells using quantum dot bioconjugates" 21 : 47-51, 2003

12 Hotta, N, "Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial" 29 : 1538-1544, 2006

13 Miller, S. I, "LPS, TLR4 and infectious disease diversity" 3 : 36-46, 2005

14 Obrosova, I. G, "Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications" 7 : 1543-1552, 2005

15 Wu, X, "Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots" 21 : 41-46, 2003

16 Vedantham, S, "Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice" 31 : 1805-1813, 2011

17 Chen, X. P, "HPLC-fluorescence detect the activity of aldose reductase" 28 : 1472-1475, 2012

18 Haverkamp, S, "Expression analysis of green fluorescent protein in retinal neurons of four transgenic mouse lines" 160 : 126-139, 2009

19 Zhu, G. Q, "Experimental study on dog's bone marrow stem cells transfected by pIRES2-EGFP-IGF-1 gene" 41 : 739-742, 2006

20 Reddy, G. B, "Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy" 14 : 593-601, 2008

21 Lee, A. Y, "Contributions of polyol pathway to oxidative stress in diabetic cataract" 13 : 23-30, 1999

22 Hu, Z. Y, "Construction of delta-pIRES2-EGFP plasmid and its expression in HEK293 cells" 29 : 1351-1353, 2009

23 Du, M. M, "Construction and function study of a drug screening model based on aldose reductase gene and its inhibitor" 25 : 552-555, 2009

24 Yong, K. T, "Anti-claudin-4-conjugated highly luminescent nanoparticles as biological labels for pancreatic cancer sensing" 762 : 427-438, 2011

25 Petrash, J. M, "All in the family: Aldose reductase and closely related aldo-keto reductases" 61 : 737-749, 2004

26 Ramana, K. V, "Aldose reductase: A novel therapeutic target for inflammatory pathologies" 42 : 17-20, 2010

27 Alexiou, P, "Aldose reductase enzyme and its implication to major health problems of the 21(st) century" 16 : 734-752, 2009

28 Plebani, A, "A new immunoperoxidase assay for Lolium perenne-specific IgE in serum based on the biotin/avidin system (BAS)" 14 : 373-378, 1984